Inotiv, Inc. (NOTV)
USD 2.03
(2.53%)
USD 2.03
(2.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 856.53 Million USD | -11.05% |
| 2022 | 962.9 Million USD | 199.17% |
| 2021 | 321.85 Million USD | 422.55% |
| 2020 | 61.59 Million USD | 46.72% |
| 2019 | 41.98 Million USD | 34.26% |
| 2018 | 31.26 Million USD | 53.15% |
| 2017 | 20.41 Million USD | -3.42% |
| 2016 | 21.13 Million USD | -11.24% |
| 2015 | 23.81 Million USD | 0.17% |
| 2014 | 23.77 Million USD | -7.12% |
| 2013 | 25.59 Million USD | -5.11% |
| 2012 | 26.97 Million USD | -16.6% |
| 2011 | 32.34 Million USD | 8.75% |
| 2010 | 29.74 Million USD | -8.72% |
| 2009 | 32.58 Million USD | -19.24% |
| 2008 | 40.34 Million USD | -4.02% |
| 2007 | 42.03 Million USD | -0.65% |
| 2006 | 42.31 Million USD | -11.55% |
| 2005 | 47.83 Million USD | 2.23% |
| 2004 | 46.79 Million USD | 4.02% |
| 2003 | 44.98 Million USD | 34.43% |
| 2002 | 33.46 Million USD | 19.61% |
| 2001 | 27.97 Million USD | 4.93% |
| 2000 | 26.66 Million USD | 1.38% |
| 1999 | 26.3 Million USD | 17.94% |
| 1998 | 22.3 Million USD | 40.25% |
| 1997 | 15.9 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 835.51 Million USD | -2.45% |
| 2024 Q3 | 774.58 Million USD | -5.0% |
| 2024 Q2 | 815.37 Million USD | -2.41% |
| 2023 FY | 856.53 Million USD | -11.05% |
| 2023 Q4 | 856.53 Million USD | 0.2% |
| 2023 Q3 | 854.83 Million USD | -1.59% |
| 2023 Q2 | 868.66 Million USD | -0.27% |
| 2023 Q1 | 871.05 Million USD | -9.54% |
| 2022 Q1 | 1 Billion USD | 211.91% |
| 2022 Q3 | 1.16 Billion USD | 2.49% |
| 2022 Q4 | 962.9 Million USD | -17.54% |
| 2022 FY | 962.9 Million USD | 199.17% |
| 2022 Q2 | 1.13 Billion USD | 13.5% |
| 2021 Q4 | 321.85 Million USD | 87.26% |
| 2021 FY | 321.85 Million USD | 422.55% |
| 2021 Q3 | 171.87 Million USD | 166.18% |
| 2021 Q2 | 64.57 Million USD | 2.82% |
| 2021 Q1 | 62.79 Million USD | 1.96% |
| 2020 Q3 | 63.71 Million USD | 3.33% |
| 2020 Q1 | 60.91 Million USD | 45.11% |
| 2020 Q2 | 61.66 Million USD | 1.23% |
| 2020 Q4 | 61.59 Million USD | -3.34% |
| 2020 FY | 61.59 Million USD | 46.72% |
| 2019 FY | 41.98 Million USD | 34.26% |
| 2019 Q4 | 41.98 Million USD | 8.63% |
| 2019 Q3 | 38.64 Million USD | 21.59% |
| 2019 Q2 | 31.78 Million USD | 2.85% |
| 2019 Q1 | 30.9 Million USD | -1.17% |
| 2018 Q4 | 31.26 Million USD | 45.07% |
| 2018 FY | 31.26 Million USD | 53.15% |
| 2018 Q3 | 21.55 Million USD | 5.65% |
| 2018 Q2 | 20.4 Million USD | -0.63% |
| 2018 Q1 | 20.53 Million USD | 0.55% |
| 2017 Q2 | 20.98 Million USD | -0.63% |
| 2017 FY | 20.41 Million USD | -3.42% |
| 2017 Q1 | 21.12 Million USD | -0.09% |
| 2017 Q3 | 20.39 Million USD | -2.82% |
| 2017 Q4 | 20.41 Million USD | 0.11% |
| 2016 Q2 | 23.03 Million USD | 5.79% |
| 2016 Q1 | 21.77 Million USD | -8.57% |
| 2016 Q4 | 21.13 Million USD | -10.1% |
| 2016 FY | 21.13 Million USD | -11.24% |
| 2016 Q3 | 23.51 Million USD | 2.08% |
| 2015 Q2 | 23 Million USD | -3.12% |
| 2015 Q4 | 23.81 Million USD | 1.93% |
| 2015 Q1 | 23.74 Million USD | -0.11% |
| 2015 Q3 | 23.36 Million USD | 1.55% |
| 2015 FY | 23.81 Million USD | 0.17% |
| 2014 Q2 | 24.25 Million USD | 0.55% |
| 2014 Q3 | 24.85 Million USD | 2.49% |
| 2014 Q4 | 23.77 Million USD | -4.35% |
| 2014 Q1 | 24.11 Million USD | -5.77% |
| 2014 FY | 23.77 Million USD | -7.12% |
| 2013 Q4 | 25.59 Million USD | 5.88% |
| 2013 FY | 25.59 Million USD | -5.11% |
| 2013 Q3 | 24.17 Million USD | -2.48% |
| 2013 Q2 | 24.79 Million USD | -1.09% |
| 2013 Q1 | 25.06 Million USD | -7.08% |
| 2012 Q2 | 29.67 Million USD | -6.33% |
| 2012 Q4 | 26.97 Million USD | -6.27% |
| 2012 Q3 | 28.78 Million USD | -3.02% |
| 2012 FY | 26.97 Million USD | -16.6% |
| 2012 Q1 | 31.68 Million USD | -2.04% |
| 2011 Q4 | 32.34 Million USD | -5.72% |
| 2011 Q1 | 29.06 Million USD | -2.3% |
| 2011 Q2 | 28.93 Million USD | -0.43% |
| 2011 Q3 | 34.31 Million USD | 18.57% |
| 2011 FY | 32.34 Million USD | 8.75% |
| 2010 Q3 | 30.01 Million USD | -1.06% |
| 2010 FY | 29.74 Million USD | -8.72% |
| 2010 Q2 | 30.33 Million USD | 0.39% |
| 2010 Q1 | 30.22 Million USD | -7.25% |
| 2010 Q4 | 29.74 Million USD | -0.91% |
| 2009 Q4 | 32.58 Million USD | -5.11% |
| 2009 Q2 | 35.46 Million USD | -2.6% |
| 2009 FY | 32.58 Million USD | -19.24% |
| 2009 Q1 | 36.41 Million USD | -9.75% |
| 2009 Q3 | 34.34 Million USD | -3.18% |
| 2008 Q2 | 40.34 Million USD | 2.72% |
| 2008 FY | 40.34 Million USD | -4.02% |
| 2008 Q1 | 39.27 Million USD | -6.56% |
| 2008 Q3 | 40.8 Million USD | 1.15% |
| 2008 Q4 | 40.34 Million USD | -1.13% |
| 2007 Q2 | 41.57 Million USD | -0.12% |
| 2007 Q4 | 42.03 Million USD | 2.3% |
| 2007 Q3 | 41.09 Million USD | -1.17% |
| 2007 FY | 42.03 Million USD | -0.65% |
| 2007 Q1 | 41.63 Million USD | -1.61% |
| 2006 Q3 | 43.63 Million USD | -4.77% |
| 2006 Q4 | 42.31 Million USD | -3.04% |
| 2006 Q1 | 48.46 Million USD | 1.3% |
| 2006 Q2 | 45.82 Million USD | -5.44% |
| 2006 FY | 42.31 Million USD | -11.55% |
| 2005 Q4 | 47.83 Million USD | 0.55% |
| 2005 Q2 | 44.69 Million USD | -9.63% |
| 2005 Q1 | 49.45 Million USD | 5.68% |
| 2005 Q3 | 47.57 Million USD | 6.46% |
| 2005 FY | 47.83 Million USD | 2.23% |
| 2004 Q3 | 47.08 Million USD | 0.92% |
| 2004 FY | 46.79 Million USD | 4.02% |
| 2004 Q4 | 46.79 Million USD | -0.61% |
| 2004 Q1 | 47.06 Million USD | 4.61% |
| 2004 Q2 | 46.65 Million USD | -0.87% |
| 2003 Q1 | 39.12 Million USD | 16.93% |
| 2003 Q4 | 44.98 Million USD | 1.01% |
| 2003 FY | 44.98 Million USD | 34.43% |
| 2003 Q3 | 44.53 Million USD | 16.34% |
| 2003 Q2 | 38.28 Million USD | -2.16% |
| 2002 Q1 | 28.19 Million USD | 0.79% |
| 2002 Q3 | 31.34 Million USD | 3.62% |
| 2002 Q4 | 33.46 Million USD | 6.76% |
| 2002 FY | 33.46 Million USD | 19.61% |
| 2002 Q2 | 30.25 Million USD | 7.27% |
| 2001 Q1 | 26.81 Million USD | 0.57% |
| 2001 Q4 | 27.97 Million USD | 4.94% |
| 2001 FY | 27.97 Million USD | 4.93% |
| 2001 Q2 | 28.19 Million USD | 5.15% |
| 2001 Q3 | 26.65 Million USD | -5.45% |
| 2000 Q1 | 25.8 Million USD | -1.9% |
| 2000 Q2 | 25.93 Million USD | 0.52% |
| 2000 Q3 | 25.96 Million USD | 0.13% |
| 2000 Q4 | 26.66 Million USD | 2.67% |
| 2000 FY | 26.66 Million USD | 1.38% |
| 1999 Q3 | 24.9 Million USD | 3.75% |
| 1999 Q4 | 26.3 Million USD | 5.62% |
| 1999 FY | 26.3 Million USD | 17.94% |
| 1999 Q1 | 22.1 Million USD | -0.9% |
| 1999 Q2 | 24 Million USD | 8.6% |
| 1998 Q3 | 20.5 Million USD | 1.49% |
| 1998 FY | 22.3 Million USD | 40.25% |
| 1998 Q2 | 20.2 Million USD | 0.0% |
| 1998 Q1 | 20.2 Million USD | 26.8% |
| 1998 Q4 | 22.3 Million USD | 8.78% |
| 1997 FY | 15.9 Million USD | 0.0% |
| 1997 Q4 | 15.93 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -333.895% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -6174.22% |
| Aspira Women's Health Inc. | 6.26 Million USD | -13578.218% |
| Biodesix, Inc. | 99.09 Million USD | -764.344% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -7413.557% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -10318.106% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -10318.106% |
| Bionano Genomics, Inc. | 214.4 Million USD | -299.493% |
| CareDx, Inc | 484.61 Million USD | -76.744% |
| Check-Cap Ltd. | 25.01 Million USD | -3323.792% |
| Castle Biosciences, Inc. | 477.81 Million USD | -79.261% |
| DarioHealth Corp. | 96.38 Million USD | -788.618% |
| Exact Sciences Corporation | 6.47 Billion USD | 86.764% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 32.721% |
| Guardant Health, Inc. | 1.78 Billion USD | 52.053% |
| ICON Public Limited Company | 16.98 Billion USD | 94.959% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 73.725% |
| Illumina, Inc. | 10.11 Billion USD | 91.529% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -6116.26% |
| iSpecimen Inc. | 15.81 Million USD | -5314.518% |
| Standard BioTools Inc. | 323.06 Million USD | -165.125% |
| MDxHealth SA | 129.13 Million USD | -563.298% |
| 23andMe Holding Co. | 395.16 Million USD | -116.751% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 48.303% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 28.545% |
| Mainz Biomed B.V. | 15.4 Million USD | -5458.624% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -12581.544% |
| NeoGenomics, Inc. | 1.68 Billion USD | 49.053% |
| Neogen Corporation | 4.58 Billion USD | 81.315% |
| Natera, Inc. | 1.45 Billion USD | 41.218% |
| OPKO Health, Inc. | 2.01 Billion USD | 57.423% |
| Psychemedics Corporation | 13.27 Million USD | -6354.635% |
| Prenetics Global Limited | 254.17 Million USD | -236.99% |
| Prenetics Global Limited | 254.17 Million USD | -236.99% |
| Precipio, Inc. | 18.1 Million USD | -4631.949% |
| Personalis, Inc. | 225.09 Million USD | -280.513% |
| RadNet, Inc. | 2.88 Billion USD | 70.328% |
| Sera Prognostics, Inc. | 95.44 Million USD | -797.444% |
| Sotera Health Company | 3.13 Billion USD | 72.638% |
| Neuronetics, Inc. | 115.83 Million USD | -639.465% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -884.812% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -884.812% |
| Trinity Biotech plc | 59.43 Million USD | -1341.121% |
| Twist Bioscience Corporation | 776.4 Million USD | -10.32% |
| Exagen Inc. | 56.94 Million USD | -1404.162% |